Answers are grounded in this paper and cite their sources.
Randomized trial demonstrates that tailored umbrella interventions improve self-management and cognitive function in COPD, indicating the value of personalized behavioral care.
To evaluate the effectiveness of a multicomponent umbrella precise intervention on self-management behavior, cognitive function, and patient activation in COPD patients, and to explore the differences across three predefined patient subgroups defined by combined cognitive-activation status. Based on the IMB Model, participants were divided into three subgroups, namely: low cognition-low activation (LC-LA group); low cognition-normal activation (LC-NA group) and normal cognition-low activation (NC-LA group), randomly assigned to intervention or control group. Patients in the intervention group received a 5-week general program (HKGP) delivering COPD education covering exercise, respiratory training, inhalation, oxygen therapy, and cognitive prevention. Two targeted plans were offered: (1) ICTP program for MoCA < 26 (LC-LA and LC-NA group), using a home-based digital system “Liuliu Brain” for 30 min, 3–5 times/week for 12 weeks, to improve cognitive function. (2) MIP program for PAM < 55.1(LC-LA and NC-LA group), consisting of four biweekly 15–20 min motivational interviews from week 6 to 12, focusing on goal-setting and behavioral discrepancy. Controls received routine self-management education and booklets. Self-management, MoCA, patient activation, inhaler adherence and quality of life were measured at baseline, post-intervention and the 6-month follow-up, and the improvement of all results in each subgroup of the intervention group was compared. A total of 66 participants were included. However, 4 participants withdrew during the intervention period due to worsening of their conditions. As a result, 62 participants were finally included, and 30 were allocated to the intervention group and 32 to the control group. The intervention group showed significant improvements in cognitive function (MoCA), self-management, patient activation, inhaler adherence, and quality of life from baseline to post-intervention, all sustained at 6-month follow-up (all P < 0.001). In contrast, the control group exhibited no improvement, with self-management and activation declining over time ( P < 0.001). Repeated-measures ANOVA revealed significant time×group interactions for all primary outcomes except the group main effect for MoCA, with effect sizes (partial η² 0.240 to 0.818). The exploratory results from subgroup analyses may suggest differential responses: patients with low cognition-low activation gained most in self-management and activation; those with normal cognition-low activation had the greatest activation improvement; those with low cognition-normal activation achieved the largest self-management gains initially but declined at the 6-month follow-up. The umbrella precise intervention yielded significant and sustained improvements in self-management, cognition, patient activation, inhaler adherence, and quality of life in COPD. Despite non-significant MoCA group main effect, the significant time×group interaction confirms cognitive benefit over time. Positive effects on self-management and activation were observed. Subgroup analyses revealed differential responsiveness across baseline cognitive-activation profiles, suggesting that tailored strategies may be necessary to optimize treatment outcomes for distinct patient subgroups. Furthermore, further large-scale and longer-term studies are warranted.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: